MANIFESTACIONES CUTÁNEAS DE COVID-19

Recalcati S. Cutaneous manifestations in COVID‐19: a first perspective. J Eur Acad Dermatol Venereol. 2020 Mar 26. doi: 10.1111/jdv.16387.

https://www.ncbi.nlm.nih.gov/pubmed/32215952

https://onlinelibrary.wiley.com/doi/abs/10.1111/jdv.16387

Rademaker M, Baker C, Foley P, Sullivan J, Wang, C. Advice regarding COVID-19 and use of immunomodulators, in patients with severe dermatological diseases. Australas J Dermatol 2020. Accepted Author Manuscript. doi:10.1111/ajd.13295.

https://onlinelibrary.wiley.com/doi/epdf/10.1111/ajd.13295

Zhang Y., Cao W., Xiao M. et Al. 2020. Clinical and Coagulation Characteristics of 7 Patients With Critical COVID-2019 Pneumonia and Acro-Ischemia. Zhonghua Xue Ye Xue Za Zhi 41 (0), E006 2020 Mar 28

https://www.ncbi.nlm.nih.gov/pubmed/32220276

Mazzotta F, Troccoli T. Monday’s case: Acute acro-ischemia in the child at the time of COVID-19. European Journal of Pediatric Dermatolgy.

https://www.ejpd.com/images/acroischemia-ENG.pdf

Chen Y, Peng H, Wang L, Zhao Y, Zeng L, Gao H, Liu Y. Infants born to mothers with a new coronavirus (COVID-19). Front Pediatr. 2020 Mar 16;8:104. doi: 10.3389/fped.2020.00104

https://doi.org/10.3389/fped.2020.00104

Joob, B, Wiwanitkit, V.  COVID-19 can present with a rash and be mistaken for Dengue.
J Am Acad Dermatol. 2020 Mar 22. pii: S0190-9622(20)30454-0. doi: 10.1016/j.jaad.2020.03.036

https://doi.org/10.1016/j.jaad.2020.03.036

Yan Zhang, M.D. et al. Correspondence Covid-19 Cases: Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19.NEJM April 8, 2020 DOI: 10.1056/NEJMc2007575

https://www.nejm.org/doi/full/10.1056/NEJMc2007575

Darlenski R, Tsankov N. Covid-19 pandemic and the skin – What should dermatologists know? Clin Dermatol. 2020 Mar 24 doi: 10.1016/j.clindermatol.2020.03.012

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102542/

COVID-19 Y SU RELACIÓN CON EL OLFATO

Gane SB, Kelly C, Hopkins C. Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome? Rhinology. 2020 Apr 2. doi: 10.4193/Rhin20.114. PMID: 32240279 DOI: 10.4193/Rhin20.114

Eliezer M, Hautefort C, Hamel A, et al. Sudden and Complete Olfactory Loss Function as a Possible Symptom of COVID-19. JAMA Otolaryngol Head Neck Surg. Published online April 08, 2020. doi:10.1001/jamaoto.2020.0832

TERAPIAS BIOLÓGICAS Y COVID-19

Wang C, Rademaker M, Baker C, Foley P. COVID-19 and the use of immunomodulatory and biologic agents for severe cutaneous disease: An Australia/New Zealand consensus statement.
Australas J Dermatol. 2020 Apr 7. doi: 10.1111/ajd.13313.

https://doi.org/10.1111/ajd.13313

Balogh EA, Heron C, Feldman SR, Huang WW. SECURE-Psoriasis: A de-identified registry of psoriasis patients diagnosed with COVID-19. J Dermatolog Treat. 2020 Apr 8:1-2. doi: 10.1080/09546634.2020.1753996

https://doi.org/10.1080/09546634.2020.1753996

Shanshal M. Biological treatment use amid the COVID-19 era, a close look at the unresolved perplexity. J Dermatolog Treat. 2020 Apr 7:1-9. doi: 10.1080/09546634.2020.1752886

https://doi.org/10.1080/09546634.2020.1752886

Bardazzi F, Loi C, Sacchelli L, Di Altobrando A. Biologic therapy for psoriasis during the covid-19 outbreak is not a choice. J Dermatolog Treat. 2020 Apr 6:1-2. doi: 10.1080/09546634.2020.1749545.

https://doi.org/10.1080/09546634.2020.1749545

Kansal NK. COVID-19, syphilis and biologic therapies for psoriasis and psoriatic arthritis: A word of caution. J Am Acad Dermatol. 2020 Apr 1. pii: S0190-9622(20)30502-8. doi: 10.1016/j.jaad.2020.03.079

https://doi.org/10.1016/j.jaad.2020.03.079

Shah P, Zampella JG. Use of systemic immunomodulatory therapies during the coronavirus disease 2019 (COVID-19) pandemic. J Am Acad Dermatol. 2020 Mar 31. pii: S0190-9622(20)30478-3. doi: 10.1016/j.jaad.2020.03.056.

https://doi.org/10.1016/j.jaad.2020.03.056

Abdelmaksoud A, Goldust M, Vestita M. Comment on «COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action». Dermatol Ther. 2020 Apr 1:e13360. doi: 10.1111/dth.13360

https://doi.org/10.1111/dth.13360

Di Lernia V. Antipsoriatic treatments during COVID-19 outbreak. Dermatol Ther. 2020 Mar 29:e13345. doi: 10.1111/dth.13345

https://doi.org/10.1111/dth.13345

Sriwijitalai W, Wiwanitkit V. Biological treatment during COVID-19 outbreak. J Dermatolog Treat. 2020 Mar 28:1. doi: 10.1080/09546634.2020.1749548.

https://doi.org/10.1080/09546634.2020.1749548

COVID-19 and immunomodulator/immunosuppressant use in dermatology.
Price KN, Frew JW, Hsiao JL, Shi VY.
J Am Acad Dermatol. 2020 Mar 26. pii: S0190-9622(20)30466-7. doi: 10.1016/j.jaad.2020.03.046

https://doi.org/10.1016/j.jaad.2020.03.046 

Rademaker M, Baker C, Foley P, Sullivan J, Wang C.Advice regarding COVID-19 and use of immunomodulators, in patients with severe dermatological diseases. Australas J Dermatol. 2020 Mar 26. doi: 10.1111/ajd.13295

https://www.ncbi.nlm.nih.gov/pubmed/32219857

Lebwohl M, Rivera-Oyola R, Murrell DF.Should biologics for psoriasis be interrupted in the era of COVID-19? J Am Acad Dermatol. 2020 Mar 18. pii: S0190-9622(20)30445-X. doi: 10.1016/j.jaad.2020.03.031

https://doi.org/10.1016/j.jaad.2020.03.031

Bashyam AM, Feldman SR. Should patients stop their biologic treatment during the COVID-19 pandemic. J Dermatolog Treat. 2020 Mar 19:1-2. doi: 10.1080/09546634.2020.1742438.

https://doi.org/10.1080/09546634.2020.1742438

Conforti C, Giuffrida R, Dianzani C, Di Meo N, Zalaudek I. COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action. Dermatol Ther. 2020 Mar 11:e13298. doi: 10.1111/dth.13298

https://doi.org/10.1111/dth.13298

PSORIASIS Y COVID

Balogh EA, Heron C, Feldman SR, Huang WW. SECURE-Psoriasis: A de-identified registry of psoriasis patients diagnosed with COVID-19. J Dermatolog Treat. 2020 Apr 8:1-2. doi: 10.1080/09546634.2020.1753996

https://doi.org/10.1080/09546634.2020.1753996

Kutlu Ö, Metin A. A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic? Dermatol Ther. 2020 Apr 7:e13383. doi: 10.1111/dth.13383.

https://doi.org/10.1111/dth.13383

Arora G, Kassir M, Jafferany M, et al. The COVID-19 outbreak and rheumatologic skin diseases.
Dermatol Ther. 2020 Mar 31:e13357. doi: 10.1111/dth.13357

https://doi.org/10.1111/dth.13357

Di Lernia V. Antipsoriatic treatments during COVID-19 outbreak. Dermatol Ther. 2020 Mar 29:e13345. doi: 10.1111/dth.13345.

https://doi.org/10.1111/dth.13345

CÁNCER DE PIEL Y COVID-19

Villani A, Fabbrocini G, Costa C, Scalvenzi M. Patients with advanced basal cell carcinomas in treatment with sonic hedgehog inhibitors during the coronavirus disease 2019 (COVID-19) period: Management and adherence to treatment. J Am Acad Dermatol. 2020 Mar 31. pii: S0190-9622(20)30479-5. doi: 10.1016/j.jaad.2020.03.057

https://doi.org/10.1016/j.jaad.2020.03.057